Performance-enhancing aids in sport: health consequences and nutritional alternatives.

References

• Catlin DH, Kammerer RC, Hatton CK, Sekera MH, Merdink JL: Analytical chemistry at the games of the XXIIIrd Olympiad in Los Angeles 1984. Clin Chem 33: 319–327, 1987.
   PubMed Web of Science ®Google Scholar
• Hill JA, Suker JR, Sachs K, Brigham C: The athletic polydrug abuse phenomenon. Am J Sports Med 11: 269–271, 1983.
   PubMed Web of Science ®Google Scholar
• Kleiner SM, Calabrese LH, Fiedler KM, Naito HK, Skibinski CI: Dietary influences on cardiovascular disease risk in anabolic steroid-using and non-using bodybuilders. J Am Coll Nutr 8: 109–119, 1989.
   PubMed Web of Science ®Google Scholar
• Faber M, Benade AJS, Van Eck M: Dietary intake, anthropometric measurements, and blood lipid values in weight training athletes (bodybuilders). Int J Sports Med 7: 342–346, 1986.
   PubMed Web of Science ®Google Scholar
• Kleiner SM, Bazzarre TL, Litchford MD: Metabolic profiles, diet, and health practices of championship male and female bodybuilders. J Am Diet Assoc 90: 962–967, 1990.
   PubMed Web of Science ®Google Scholar
• Bazzarre TL, Kleiner SM, Litchford MD: Nutrient intake, body fat, and lipid profiles of competitive male and female bodybuilders. J Am Coll Nutr 9: 136–142, 1990.
   PubMed Web of Science ®Google Scholar
• Kochakian CD, Murlin JR: The effect of male hormones on the protein and energy metabolism of castrate dogs. J Nutr 10: 437–458, 1935.
   Google Scholar
• Kenyon AT, Sandiford I, Bryan AH, Knowlton K, Koch FC: Effect of testosterone propionate on nitrogen, electrolyte, water and energy metabolism in eunuchoidism. Endocrinology 23: 135–153, 1938.
   Google Scholar
• Papanicolaou HN, Falk GA: General muscular hypertrophy induced by androgenic hormone. Science 87: 238–239, 1938.
   PubMedGoogle Scholar
• Kenyon AT, Knowlton K, Sandiford I, Koch FC, Lotwin G: A comparative study of the metabolic effects of testosterone propionate in normal men and women and in eunuchoidism. Endocrinology 26: 26–45, 1940.
   Google Scholar
• Kenyon AT, Knowlton K, Sandiford I: The anabolic effects of the androgens and somatic growth in man. Ann Intern Med 20: 632–654, 1944.
   Google Scholar
• Hershberger JG, Shipley EG, Meyer RK: Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method. Proc Soc Exp Biol Med 83: 175–180, 1953.
   PubMed Web of Science ®Google Scholar
• Todd T: The steroid predicament. Sports Illust l(Aug):62–77, 1983.
   Google Scholar
• Wilson JD, Griffin JE: The use and misuse of androgens. Metabolism 9: 1278–1295, 1980.
   Google Scholar
• Lombardo JA, Longscope C, Voy RO: Recognizing anabolic steroid abuse. Patient Care 19: 28–47, 1985.
   Google Scholar
• Cowart V: Steroids in sports. After four decades time to return these genies to the bottle? JAMA 257: 421–427, 1987.
   PubMed Web of Science ®Google Scholar
• Cowart V: Issues of drugs and sports gain attention as Olympic Games open in South Korea. JAMA 260: 1513–1518, 1988.
   PubMedGoogle Scholar
• Kibble WM, Ross MB: Adverse effects of anabolic steroids in athletes. Clin Pharm 6: 686–692, 1987.
   PubMedGoogle Scholar
• Dilley WG, Haagensen DE Jr, Leight GS Jr, Annirata S, Davis SR, Silva JS, Zamcheck N, Lokich JJ, Wells SA Jr: Fluoxymesterone stimulation of tumor marker secretion in patients with breast carcinoma. Breast Cancer Res Treat 8: 205–215, 1986.
   PubMedGoogle Scholar
• Kavanagh JJ, Wharton JT, Robert WS: Androgen therapy in the treatment of refractory epithelial ovarian cancer. Cancer Treat Rep 71: 537–538, 1987.
   PubMedGoogle Scholar
• Stepaniak PC, Furst JJ, Woodard D: Anabolic steroids as a countermeasure against bone demineralization during space flight. Aviat Space Environ Med 57: 174–178, 1986.
   PubMedGoogle Scholar
• Hallagan JB, Hallagan LF, Snyder MB: Anabolic–androgenic steroid use by athletes. New Engl J Med 321: 1042–1045, 1989.
   PubMed Web of Science ®Google Scholar
• Voy R: Illicit drugs and the athlete. Am Pharm NS26:39–45, 1986.
   Google Scholar
• Wadler GI, Hainline B: “Drugs and the Athlete.” Philadelphia: FA Davis Co, 1989.
   Google Scholar
• Cowart VS: Accord on drug testing, sanctions sought before 1992 Olympics in Europe. JAMA 260: 3397–3398, 1988.
   PubMed Web of Science ®Google Scholar
• Haupt HA, Rovere GD: Anabolic steroids: a review of the literature. Am J Sports Med 12: 469–484, 1984.
   PubMed Web of Science ®Google Scholar
• Fahey TD, Brown CH: The effects of an anabolic steroid on the strength, body composition and endurance of college males when accompanied by a weight training program. Med Sci Sports 5: 272–276, 1973.
   PubMedGoogle Scholar
• Bowers RW, Reardon JP: Effects of methandrostenolone (Dianabol) on strength development and aerobic capacity. Med Sci Sports 4: 54, 1972.
   Google Scholar
• Ballarin E, Guglielmini C, Martinelli S, Casoni I, Birsetto C, Ziglio PG, Conconi F: Unmodified performance in runners following anabolic steroid administration. Int J Sports Med 7: 302–306, 1986.
   PubMedGoogle Scholar
• Ariel G: The effect of anabolic steroid (methandrostenolone) upon physiological parameters. Athl Train 7: 190–200, 1972.
   Google Scholar
• Ariel G: Residual effect of an anabolic steroid upon isotonic muscular force. J Sports Med Phys Fitness 14: 103–111, 1974.
   PubMedGoogle Scholar
• Hervey GR, Knibbs AV, Burkinshaw L, Morgan DB, Jones PR, Chettle DR, Vartsky D: Effects of methandienone on the performance and body composition of men undergoing athletic training. Clin Sci 60: 457–461, 1981.
   PubMed Web of Science ®Google Scholar
• O'Shea JP, Johnson LC: Anabolic steroids: effects on strength development. Science 164: 957–959, 1969.
   PubMedGoogle Scholar
• O'Shea JP: The effects of an anabolic steroid on dynamic strength levels of weight lifters. Nutr Reports Int 4: 363–372, 1971.
   Google Scholar
• Johnson SC, Fisher G, Silvester LJ, Hofheins CC: Anabolic steroids: effects in strength, body weight, oxygen uptake and spermatogenesis upon mature males. Med Sci Sports 4: 43–45, 1972.
   PubMedGoogle Scholar
• Johnson LC, Roundy ES, Alison PE, Fisher AG, Silvester LJ: Effect of anabolic steroid treatment on endurance. Med Sci Sports 7: 287–289, 1975.
   PubMedGoogle Scholar
• Golding LA, Freydinger JE, Fishel SS: The effect of an androgenic–anabolic steroid and a protein supplement on size, strength, weight and body composition in athletes. Phys Sportsmed 2: 39–45, 1974.
   PubMedGoogle Scholar
• American College of Sports Medicine position stand on the use of anabolic–androgenic steroids in sports. Med Sci Sports Exerc 19: 534–539, 1987.
   PubMed Web of Science ®Google Scholar
• Alen M, Hakkinen K: Androgenic steroid effects on serum hormones and on maximal force development in strength athletes. J Sports Med 27: 38–46, 1987.
   Google Scholar
• Alen M, Parkarinen A, Hakkinen K, Komi PV: Responses of serum androgenic–anabolic and catabolic hormones to prolonged strength training. Int J Sports Med 9: 229–233, 1988.
   PubMed Web of Science ®Google Scholar
• Hickson RC, Kurowski BS: Anabolic steroids and training. Clin Sports Med 5: 461–469, 1986.
   PubMed Web of Science ®Google Scholar
• Windsor RE, Dumitru D: Anabolic steroid use by athletes. How serious are the health hazards? Postgrad Med 84: 37–49, 1988.
   PubMed Web of Science ®Google Scholar
• Alen M, Rahkila P, Reinila M, Vihko R: Androgenic–anabolic steroid effects on serum thyroid, pituitary, and steroid hormones in athletes. Am J Sports Med 15: 357–361, 1987.
   PubMed Web of Science ®Google Scholar
• Lamb DR: Anabolic steroids in athletics: how well do they work and how dangerous are they? Am J Sports Med 12: 31–38, 1984.
   PubMed Web of Science ®Google Scholar
• Bower KJ, Blow FC, Beresford TP, Fuelling C: Anabolic–androgenic steroid dependence. J Clin Psych 50: 31–33, 1989.
   Google Scholar
• Tennant F, Black DL, Voy RO: Anabolic dependence with opioid-type features. New Engl J Med 319: 578, 1988.
   PubMed Web of Science ®Google Scholar
• Yesalis CE, Herrick RT, Buckley WE, Friedle KE, Brannon D, Wright JE: Self-reported use of anabolic–androgenic steroids by elite powerlifters. Phys Sportsmed 16: 91–100, 1988.
   PubMed Web of Science ®Google Scholar
• Pope HG, Katz DL: Affective and psychotic symptoms associated with anabolic steroid use. Am J Psych 145: 487–491, 1988.
   PubMed Web of Science ®Google Scholar
• Hurley BF, Seals DR, Hagberg JM, Goldberg AC, Ostrove SM, Holloszy JO, Wiest WG, Goldberg AP: High-density-lipoprotein cholesterol in bodybuilders vs powerlifters. JAMA 252: 507–513, 1984.
   PubMed Web of Science ®Google Scholar
• Burkett LN, Falduto MT: Steroid use by athletes in a metropolitan area. Phys Sportsmed 12: 69–74, 1984.
   PubMedGoogle Scholar
• Bierly JR: Use of anabolic steroids by athletes. Do the risks outweigh the benefits? Postgrad Med 82: 67–73, 1987.
   PubMed Web of Science ®Google Scholar
• Council of Scientific Affairs: Drug abuse in athletes. Anabolic steroids and human growth hormone. JAMA 259: 1703–1705, 1988.
   PubMedGoogle Scholar
• Calabrese LH, Kleiner SM, Barna BP, Skibinski CI, Kirkendall DT, Lahita RG, Lombardo JA: The effects of anabolic steroids and strength training on the human immune response. Med Sci Sports Exerc 21: 386–392, 1989.
   PubMed Web of Science ®Google Scholar
• DHHS, US Public Health Service, FDA: Anabolic steroids: losing at winning. DHHS Publication No. (FDA)88–3171, 1988.
   Google Scholar
• Strauss RH, Liggett, MT, Lanese RR: Anabolic steroid use and perceived effects in ten weight-trained women athletes. JAMA 253: 2871–2873, 1985.
   PubMed Web of Science ®Google Scholar
• Duda M: Female athletes: targets for drug abuse. Phys Sportsmed 14: 142–146, 1986.
   PubMed Web of Science ®Google Scholar
• Overly WL, Dankoff JA, Wang BK, Singh UD: Androgens and hepatocellular carcinoma in an athlete. Ann Intern Med 100: 158–159, 1984.
   PubMed Web of Science ®Google Scholar
• Goldman B: Liver carcinoma in an athlete taking anabolic steroids. J Am Osteopath Assoc 85: 56, 1985.
   PubMedGoogle Scholar
• Creagh TM, Rubin A, Evans DJ: Hepatic tumors induced by anabolic steroids in an athlete. J Clin Pathol 41: 441–443, 1988.
   PubMed Web of Science ®Google Scholar
• Roberts JT, Essenhigh DM: Adenocarcinoma of prostate in 40-year-old bodybuilder. Lancet 2: 742, 1986.
   PubMed Web of Science ®Google Scholar
• Veneri RJ, Gordon SC: Anabolic steroid-induced cholestasis: colorectic response to corticosteroids. J Clin Gastroenterol 10: 467–468, 1988.
   PubMed Web of Science ®Google Scholar
• Zeiss J, Smith RR, Taha AM: Iliopsoas hypertrophy mimicking acute abdomen in a bodybuilder. Gastrointest Radiol 12: 340–342, 1987.
   PubMedGoogle Scholar
• Sklarek HM, Mantovani RP, Erens E, Heisler D, Niederman MS, Fein AM: AIDS in a bodybuilder using anabolic steroids. New Engl J Med 311: 1701, 1984.
   PubMed Web of Science ®Google Scholar
• McKillop G, Todd IC, Ballantyne D: Increased left ventricular mass in a bodybuilder using anabolic steroids. Br J Sports Med 20: 151–152, 1986.
   PubMedGoogle Scholar
• McNutt RA, Ferenchick GS, Kirlin PC, Hamlin NJ: Acute myocardial infarction in a 22-year-old world class weightlifter using anabolic steroids. Am J Cardiol 62: 164, 1988.
   PubMed Web of Science ®Google Scholar
• Mochizuki RM, Richter KJ: Cardiomyopathy and cerebrovascular accident associated with anabolic–androgenic steroid use. Phys Sportsmed 16: 109–114, 1988.
   PubMed Web of Science ®Google Scholar
• Frankle MA, Eichberg R, Zachariah SB: Anabolic–androgenic steroids and a stroke in an athlete: case report. Arch Phys Med Rehabil 69: 632–633, 1988.
   PubMed Web of Science ®Google Scholar
• McDermott J: Steroids cited in teen's death. The Cleveland Plain Dealer, Jan 11, pp 1A, 8A, 1989.
   Google Scholar
• Cohen JC, Faber WM, Benade AJS, Noakes TD: Altered serum lipoprotein profiles in male and female power lifters ingesting anabolic steroids. Phys Sportsmed 14: 131–136, 1986.
   PubMed Web of Science ®Google Scholar
• Peterson GE, Fahey TD: HDL-C in five elite athletes using anabolic–androgenic steroids. Phys Sportsmed 12: 120–130, 1984.
   PubMedGoogle Scholar
• Costill DL, Pearson DR, Fink WJ: Anabolic steroid use among athletes: changes in HDL-C levels. Phys Sportsmed 12: 113–117, 1984.
   Google Scholar
• Strauss RH, Wright JE, Finerman GA, Catlin DH: Side effects of anabolic steroids in weight-trained men. Phys Sportsmed 11: 87–96, 1983.
   PubMedGoogle Scholar
• Hakkinen K, Alen M: Physiological performance, serum hormones, enzymes, and lipids of an elite power athlete during training with and without androgens and during prolonged detraining. J Sports Med 26: 92–100, 1986.
   Google Scholar
• Lenders JWM, Denacker PNM, Vos JA, Jansen PLM, Hoitsma AJ, Van't Laar A, Thien T: Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9: 19–23, 1988.
   PubMed Web of Science ®Google Scholar
• Cohen JC, Noakes TD, Benade AJS: Hypercholesterolemia in male power lifters using anabolic–androgenic steroids. Phys Sportsmed 16: 49–56, 1988.
   PubMed Web of Science ®Google Scholar
• Ishak KG, Zimmerman HJ: Hepatotoxic effects of the anabolic/androgenic steroids. Sem Liver Dis 7: 230–236, 1987.
   PubMed Web of Science ®Google Scholar
• Thompson PD, Cullinane EM, Sady SP, Chenevert C, Saritelli AL, Sady MA, Herbert PN: Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. JAMA 261: 1165–1168, 1989.
   PubMed Web of Science ®Google Scholar
• Pope HG, Katz DL, Champoux R: Anabolic–androgenic steroid use among 1,010 college men. Phys Sportsmed 16: 75–81, 1988.
   PubMed Web of Science ®Google Scholar
• Buckley WE, Yesalis CE, Friedl KE, Anderson WA, Streit AL, Wright JE: Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 260: 3441–3445, 1988.
   PubMed Web of Science ®Google Scholar
• Pope HG, Katz DL: Bodybuilder's psychosis. Lancet 1: 863–864, 1987.
   PubMed Web of Science ®Google Scholar
• Cowart V: Classifying steroids as controlled substances suggested to decrease athlete's supply, but enforcement could be a major problem. JAMA 257: 3029, 1987.
   PubMedGoogle Scholar
• Anonymous: Steroid use on trial. The New York Times, Apr 2, 1986.
   Google Scholar
• Janofsky M, Alfano P: System accused of failing test posed by drugs. The New York Times, Nov 17, 1988.
   Google Scholar
• Lederman D: Witnesses tell senators steroid use has reached epidemic proportions among football players. Chronicle Higher Educ A38, May 17, 1989.
   Google Scholar
• Murphy P: Steroids: not just for athletes anymore. Phys Sportsmed 14: 48, 1986.
   PubMed Web of Science ®Google Scholar
• Mannie K: Androgenic–anabolic steroids in the high school: the new drug crisis. NSCA J 10: 64–65, 1988.
   Google Scholar
• Dyment PG: The adolescent athlete and ergogenic aids. J Adol Health Care 8: 68–73, 1987.
   PubMedGoogle Scholar
• Fuller JR, La Fountain MJ: Performance-enhancing drugs in sport: a different form of drug abuse. Adolescence 22: 969–976, 1987.
   PubMed Web of Science ®Google Scholar
• Cowart V: Some predict increased steroid use in sports despite drug testing, crackdown on suppliers. JAMA 257: 3025–3026, 1987.
   PubMed Web of Science ®Google Scholar
• Puffer JC: The use of drugs in swimming. Clin Sports Med 5: 77–89, 1986.
   PubMed Web of Science ®Google Scholar
• McKillop G: Drug abuse in bodybuilders in the west of Scotland. Scott Med J 32: 39–41, 1987.
   PubMed Web of Science ®Google Scholar
• Tipton CM: Commentary: physicians should advise wrestlers about weight loss. Phys Sportsmed 15: 160, 1987.
   PubMed Web of Science ®Google Scholar
• Grandjean AC: Vitamins, diet, and the athlete. Clin Sports Med 2: 105–114, 1983.
   PubMedGoogle Scholar
• “Report of the Ross Symposium on Muscle Development: Nutritional Alternatives to Anabolic Steroids.” Columbus, OH: Ross Laboratories, 1988.
   Google Scholar
• Hickson JF, Wolinsky I: Human protein intake and metabolism in exercise and sport. In Hickson JR, Wolinsky I (eds): “Nutrition in Exercise and Sport.” Boca Raton, FL: CRC Press, 1989.
   Google Scholar
• Short SH, Short WR: Four-year study of university athletes' dietary intake. J Am Diet Assoc 82: 632–645, 1983.
   PubMed Web of Science ®Google Scholar
• Hickson J, Wolinsky I, Pivamik J, Neuman E, Itak J, Stockton J: Nutritional profile of football athletes eating from a training table. Nutr Res 1: 27–34, 1987.
   Google Scholar
• Grandjean AC: Macronutrient intake of US athletes compared with the general population and recommendations made for athletes. Am J Clin Nutr 449: 1070–1076, 1989.
   Google Scholar
• Celejowa I, Homa M: Food intake, nitrogen and energy balance in Polish weightlifters during a training camp. Nutr Metab 12: 259–274, 1970.
   PubMedGoogle Scholar
• Laritcheva KA, Yalovaya NI, Shubin VI, Smirnov PV: Study of energy expenditure and protein needs of top weight lifters. In Parizkova J, Rogozkin VA (eds): “Nutrition, Physical Fitness, and Health.” Baltimore: University Park Press, 1978.
   Google Scholar
• Marable NL, Hickson JK, Korslund MK, Herbert WG, Desjardins RF, Thye FW: Urinary nitrogen excretion as influenced by a muscle-building exercise program and protein variation. Nutr Rep Int 19: 795–804, 1979.
   Google Scholar
• Tarnopolsky MA, MacDougall JD, Altman S, Blimkie C, Sale D: Dietary protein requirements for bodybuilders versus sedentary controls. Med Sci Sports Exerc (abstract) 18: S64, 1986.
   Google Scholar
• Tarnopolsky MA, MacDougall JD, Atkinson SA: Influence of protein intake and training status on nitrogen balance and lean body mass. J Appl Physiol 64: 187–193, 1988.
   PubMed Web of Science ®Google Scholar
• Walberg JL, Leidy MK, Sturgill DJ, Hinkle DE, Ritchey SJ, Sebolt DR: Macronutrient content of a hypoenergy diet affects nitrogen retention and muscle function in weightlifters. Int J Sports Med 9: 261–266, 1988.
   PubMed Web of Science ®Google Scholar
• Harberson DA: Weight gain and body composition of weightlifters: effect of high-calorie supplementation vs anabolic steroids. In Garrett WE Jr, Malone TE (eds): “Muscle Development: Nutritional Alternatives to Anabolic Steroids.” Columbus, OH: Ross Laboratories, 1988.
   Google Scholar
• Jacobson BH: Effect of amino acids on growth hormone release. Phys Sportsmed 18: 63–70, 1990.
   PubMed Web of Science ®Google Scholar
• Bucci L, Hickson JF, Pivarnik JM, Wolinsky I, McMahon JC, Turner SD: Ornithine ingestion and growth hormone release in bodybuilders. Nutr Res 10: 239–245, 1990.
   Web of Science ®Google Scholar